Bridging Healthcare Equity: Digital Therapeutics and Breaking Down Stigma
In this podcast episode, we delve into the critical topics of healthcare equity, digital therapeutics, and dismantling stigma in healthcare access. Our guest, Autumn Brennan, Director of Communications at the Digital Therapeutics Alliance (DTA), shares her insights into how digital health technologies can bridge gaps in healthcare access, particularly in rural and marginalized communities.
We explore the challenges and opportunities in addressing healthcare disparities, focusing on the impact of digital therapeutics on mental health and marginalized groups. Autumn discusses her work in advocacy, legislative change, and messaging strategies to promote equitable healthcare access.
Additionally, Autumn introduces the DTA’s Evaluation Toolkit, which provides criteria to assess these tools, including clinical validation, data security, equitable access and more. It’s a science-based resource to guide adoption. Key factors are evidence of improved outcomes and seamless integration into workflows. This toolkit enables informed decisions to provide patients high-quality, effective digital therapeutics.
Join us for a thought-provoking conversation on these critical issues and gain valuable insights into healthcare equity, digital therapeutics, and compassionate communication in healthcare.
About the guest
As the Director of Marketing and Communications, Autumn leads the strategic marketing, public relations, and media efforts for the Digital Therapeutics Alliance, with the goal of building a unified, knowledgeable, and empowered community of stakeholders worldwide. Her experience spans product development and marketing strategies to advance dynamic, global business initiatives and drive innovation within EduTech, FinTech, Manufacturing, and Digital Health. Prior to her tech career, Autumn held a private practice in family medicine and midwifery, specifically within rural and marginalized communities. Her profound dedication to patient rights, healthcare equity, and social justice fuels her mission to see digital therapeutics reach their full potential to improve patient outcomes on a global scale.